Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.32 USD | -1.59% | -4.21% | +65.52% |
05-07 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
05-01 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+65.52% | 3.03B | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.26% | 21.58B | |
-11.25% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- SMMT Stock
- News Summit Therapeutics Inc.
- Transcript : Summit Therapeutics plc, Q2 2019 Earnings Call, Sep 20, 2018